Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

963 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Eggermont AMM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C; EORTC Melanoma Group. Eggermont AMM, et al. Among authors: puig s. Lancet Oncol. 2021 May;22(5):643-654. doi: 10.1016/S1470-2045(21)00065-6. Epub 2021 Apr 12. Lancet Oncol. 2021. PMID: 33857412 Clinical Trial.
Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study.
Davies JR, Randerson-Moor J, Kukalizch K, Harland M, Kumar R, Madhusudan S, Nagore E, Hansson J, Höiom V, Ghiorzo P, Gruis NA, Kanetsky PA, Wendt J, Pjanova D, Puig S, Saiag P, Schadendorf D, Soufir N, Okamoto I, Affleck P, García-Casado Z, Ogbah Z, Ozola A, Queirolo P, Sucker A, Barrett JH, van Doorn R, Bishop DT, Newton-Bishop J. Davies JR, et al. Among authors: puig s. Pigment Cell Melanoma Res. 2012 May;25(3):384-94. doi: 10.1111/j.1755-148X.2012.00982.x. Epub 2012 Mar 16. Pigment Cell Melanoma Res. 2012. PMID: 22325793 Free PMC article.
Genetic variation at KIT locus may predispose to melanoma.
Bourillon A, Hu HH, Hetet G, Lacapere JJ, André J, Descamps V, Basset-Seguin N, Ogbah Z, Puig S, Saiag P, Bagot M, Bensussan A, Grandchamp B, Dumaz N, Soufir N. Bourillon A, et al. Among authors: puig s. Pigment Cell Melanoma Res. 2013 Jan;26(1):88-96. doi: 10.1111/pcmr.12032. Epub 2012 Nov 23. Pigment Cell Melanoma Res. 2013. PMID: 23020152
High nevus counts confer a favorable prognosis in melanoma patients.
Ribero S, Davies JR, Requena C, Carrera C, Glass D, Rull R, Vidal-Sicart S, Vilalta A, Alos L, Soriano V, Quaglino P, Traves V, Newton-Bishop JA, Nagore E, Malvehy J, Puig S, Bataille V. Ribero S, et al. Among authors: puig s. Int J Cancer. 2015 Oct 1;137(7):1691-8. doi: 10.1002/ijc.29525. Epub 2015 Apr 11. Int J Cancer. 2015. PMID: 25809795 Free PMC article.
Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma.
Tejera-Vaquerizo A, Nagore E, Puig S, Robert C, Saiag P, Martín-Cuevas P, Gallego E, Herrera-Acosta E, Aguilera J, Malvehy J, Carrera C, Cavalcanti A, Rull R, Vilalta-Solsona A, Lannoy E, Boutros C, Benannoune N, Tomasic G, Aegerte P, Vidal-Sicart S, Palou J, Alos LL, Requena C, Traves V, Pla Á, Bolumar I, Soriano V, Guillén C, Herrera-Ceballos E. Tejera-Vaquerizo A, et al. Among authors: puig s. Eur J Cancer. 2015 Sep;51(13):1780-93. doi: 10.1016/j.ejca.2015.05.023. Epub 2015 Jun 10. Eur J Cancer. 2015. PMID: 26072362 Free PMC article.
Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma.
Lacouture ME, Dréno B, Ascierto PA, Dummer R, Basset-Seguin N, Fife K, Ernst S, Licitra L, Neves RI, Peris K, Puig S, Sokolof J, Sekulic A, Hauschild A, Kunstfeld R. Lacouture ME, et al. Among authors: puig s. Oncologist. 2016 Oct;21(10):1218-1229. doi: 10.1634/theoncologist.2016-0186. Epub 2016 Aug 10. Oncologist. 2016. PMID: 27511905 Free PMC article. Review.
Unknown Primary Melanoma: Worldwide Survey on Clinical Management.
Ribero S, Pampena R, Bataille V, Moscarella E, Thomas L, Quaglino P, Potenza C, Van Akkooi ACJ, Testori A, Nathan P, Puig S, Zalaudek I, Argenziano G, Longo C. Ribero S, et al. Among authors: puig s. Dermatology. 2016;232(6):704-707. doi: 10.1159/000453592. Epub 2017 Jan 5. Dermatology. 2016. PMID: 28052277
IRF4 rs12203592 functional variant and melanoma survival.
Potrony M, Rebollo-Morell A, Giménez-Xavier P, Zimmer L, Puig-Butille JA, Tell-Marti G, Sucker A, Badenas C, Carrera C, Malvehy J, Schadendorf D, Puig S. Potrony M, et al. Among authors: puig s, puig butille ja. Int J Cancer. 2017 Apr 15;140(8):1845-1849. doi: 10.1002/ijc.30605. Epub 2017 Feb 6. Int J Cancer. 2017. PMID: 28103633 Free article.
Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial.
Dréno B, Kunstfeld R, Hauschild A, Fosko S, Zloty D, Labeille B, Grob JJ, Puig S, Gilberg F, Bergström D, Page DR, Rogers G, Schadendorf D. Dréno B, et al. Among authors: puig s. Lancet Oncol. 2017 Mar;18(3):404-412. doi: 10.1016/S1470-2045(17)30072-4. Epub 2017 Feb 8. Lancet Oncol. 2017. PMID: 28188086 Clinical Trial.
963 results